Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells

Jessica J Miciak1,2, Lucy Petrova1, Rhythm Sajwan1

  • 1Department of Radiation Oncology and Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21231, USA.

Oncotarget
|February 19, 2025
PubMed

Insights

Restoring wild-type p53 in cancer cells impedes proliferation and increases sensitivity to radiation. Studying p53 in normal cells reveals novel targets like ALDH3A1 and NECTIN4, crucial for understanding tumor suppression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Wild-type TP53 is often lost in cancers, hindering studies on its full tumor-suppressive functions.
  • Commonly used cancer models with wild-type TP53 may not fully represent p53's capabilities.
  • Previous models like HCT116 colorectal cancer (CRC) cells, despite wild-type TP53, lack certain p53 phenotypes.

Purpose of the Study:

  • To investigate the functional impact of restoring wild-type p53 in TP53-mutant colorectal cancer cells.
  • To explore p53-dependent phenotypes in a non-cancerous cell line (hTERT-RPE1) to understand p53's broader roles.
  • To identify novel p53 target genes with potential clinical significance in cancer.

Main Methods:

  • Restoration of p53 in the TP53-mutant DLD-1 CRC cell line.
  • Disruption of TP53 in immortalized hTERT-RPE1 cells.
  • Analysis of p53-dependent phenotypes including cell proliferation, senescence, and response to ionizing radiation (IR).
  • Transcriptomic analysis to identify p53-responsive genes.

Main Results:

  • Restoring p53 in DLD-1 cells reduced proliferation, induced senescence, and increased sensitivity to IR.
  • TP53 disruption in hTERT-RPE1 cells revealed significant p53-dependent phenotypes, suggesting p53 loss is selected for during culture.
  • A p53-responsive transcriptome in hTERT-RPE1 cells was identified, serving as a model for diverse experimental systems.
  • Novel p53 targets, including ALDH3A1 (aldehyde detoxification, ROS metabolism) and NECTIN4 (cell adhesion, overexpressed in tumors), were discovered.

Conclusions:

  • Wild-type p53 actively suppresses tumor growth and enhances treatment sensitivity.
  • The hTERT-RPE1 cell line is a valuable model for studying p53 function and identifying novel targets.
  • ALDH3A1 and NECTIN4 represent potential therapeutic targets due to their roles in detoxification, metabolism, and their prevalence in tumors.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
13.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K